01 / DESIGN
What was studied?
Researchers compared two ghrelin-receptor agonists using intestinal tissue and a cisplatin-exposure ferret model.
02 / FINDINGS
What did the researchers report?
Both interventions attenuated delayed weight loss. Systemically delivered ipamorelin did not reduce acute or delayed vomiting; a central antiemetic result concerned anamorelin instead.
03 / LIMITS
How should it be interpreted?
Effects from another agonist or administration route cannot be assigned to ipamorelin. The animal experiment does not establish clinical supportive-care benefits.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.